WHO ICTRP trial
Part A Phase I, Single Ascending Dose Trial of Agomelatine in Healthy…
ACTRN12625000575437 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Recruiting
Key facts
| Trial ID | ACTRN12625000575437 |
|---|---|
| Public title | Part A Phase I, Single Ascending Dose Trial of Agomelatine in Healthy Participants |
| Scientific title | Part A: Phase 1, Single- Ascending Dose Trial to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of Agomelatine in Healthy Participants. |
| Primary sponsor | Seaport Therapeutics Australia Pty LTD |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase 1 |
| Countries | Australia |
| Conditions | Anxiety; Anxiety;Mental Health - Anxiety |
| Interventions | This study evaluates the safety, tolerability, pharmacokinetics (PK), and preliminary pharmacodynamics of agomelatine following a single oral dose in healthy adult participants. Part A - Agomelatine Intervention: Single oral dose of… |
| Registration date | Mar 6, 2025 |
| Target size | 15 |
| Secondary IDs | SPT-320-2024-101 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: